1. Keech JA, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg. 1997; 100(2): 554-555.
2. Anaplastic large cell lymphoma (ALCL) in women with breast implants: preliminary FDA findings and analyses. U.S. Food and Drug Administration, 2011. [Online] Available from: www.fda.gov.
3. Clemens MW, Horwitz SM. NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2017; 37(3): 285-289.
4. IARC monographs on the evaluation of carcinogenic risks to humans. Report of the Advisory Group to Recommend Priorities for IARC Monographs during 2015–2019, April 18, 2014. [Online] Available from: <http://monographs.iarc.fr>.
5. Treatment for health professionals. US National Cancer Institute. [Online] Available from: <http://www.cancer.gov/>.
6. Institut National du Cancer. Agence Nationale de Sécurité du Médicament. Breast implant associated anaplastic large cell lymphoma: expert opinion, February 1, 2015.
7. Clemens MW, Miranda RN. Coming of age, breast implant – associated anaplastic large cell lymphoma after 18 years of investigation. Clin Plast, Surg. 2015; 42(4).
8. Australian Therapeutic Goods Administration. Breast implants: Update on TGA monitoring of anaplastic large cell lymphoma. <https://www.tga.gov.au/alert/breast-implants- update
tgamonitoring-anaplastic-large-cell-lymphoma>.
9. Campanale A, Boldrini R, Marletta M. 22 Cases of Breast Implant-Associated ALCL: Awareness and Outcome Tracking from the Italian Ministry of Health. Plast Reconstr Surg. 2018 Jan; 141(1):
11e-19e.
10. Johnson L, O'Donoghue JM, McLean N, et al. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent. Eur J Surg Oncol. 2017 Aug; 43(8):
1393-1401.
11. De Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA. 2008; 300: 2030-2035.
12. General information about adult non-hodgkin lymphoma. National Cancer Institute, 2014. [Online] Available from: <https://www.cancer.gov/ types/lymphoma/patient/adult-nhl-treatment-pdq>.
13. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin’s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985; 66: 848-858.
14. Jacobsen E. Anaplastic large-cell lymphoma,
T-/null-cell type. Oncologist. 2006; 11: 831-840.
15. Cao YB1, Wang SS, Huang HQ. Primary breast lymphoma–a report of 27 cases with literature review. Ai Zheng. 2007; 26(1): 84-89.
16. Gholam D1, Bibeau F, El Weshi A. Primary breast lymphoma. Leuk Lymphoma. 2003; 44(7):
1173-1178.
17. Kim B, Roth C, Chung KC, et al. Anaplastic large cell lymphoma and breast implants: a systematic review. Plast Reconstr Surg. 2011; 127: 2141-2150.
18. Clemens MW, Miranda RN. Commentary on: lymphomas associated with breast implants: a review of the literature. Aesthet Surg J. 2015; 35(5):
545-547.
19. Kim B, Roth C, Young VL, et al. Anaplastic large cell lymphoma and breast implants: results from a structured expert consultation process. Plast Reconstr Surg. 2011; 128: 629-639. The authors conducted.
20. Yoshida SH, Swan S, Teuber SS, Gershwin ME. Silicone breast implants: immunotoxic and epidemiologic issues. Life Sci. 1995; 56(16):
1299-1310.
21. Ferreri AJM, Govi S, Pileri SA, Savage KJ. Anaplastic large cell lymphoma, ALK-negative. Crit Rev Oncol Hematol. 2013; 85(2): 206-215.
22. Gaudet G, Friedberg JW, Weng A, et al. Breast lymphoma associated with breast implants: two
case-reports and a review of the literature. Leuk Lymphoma. 2002; 43: 115-119.
23. Hart AM, Lechowicz MJ, Peters KK, et al. Breast implant-associated anaplastic large cell lymphoma: report of 2 cases and review of the literature. Aesthet Surg J. 2014; 34(6): 884-894.
24. Lipworth L, Tarone RE, McLaughlin JK. Breast implants and lymphoma risk: a review of the epidemiologic evidence through 2008. Plast Reconstr Surg. 2009; 123: 790-793.
25. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/ BreastImplants/ucm481899.htm.
26. de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA. 2008; 300: 2030-2035
27. Largent J, Oefelein M, Kaplan HM, et al. Risk of lymphoma in women with breast implants: analysis of clinical studies. Eur J Cancer Prev. 2012; 21:
274-280.
28. Brinton LA. The relationship of silicone breast implants and cancer at other sites. Plast Reconstr Surg. 2007; 120(7 suppl 1): 94S-102S.
29. Lipworth L, Tarone RE, McLaughlin JK. Breast implants and lymphoma risk: a review of the epidemiologic evidence through 2008. Plast Reconstr Surg. 2009; 123(3): 790-793.
30. Loch-Wilkinson A, Beath KJ, Knight RJW. Et al. Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand:
High-Surface-Area Textured Implants Are Associated with Increased Risk. Plast Reconstr Surg. 2017 Oct; 140(4): 645-654.
31. Australian Therapeutic Goods Administration. Breast implants: Update on TGA monitoring of anaplastic large cell lymphoma. https://www.tga.gov.au/alert/breast-implants-update
tgamonitoring- anaplastic-large-cell-lymphoma>.
32. Zakhary JM, Hamidian Jahromi A, Chaudhery S, Kim M. Anaplastic large cell lymphoma in the setting of textured breast implant: a call for patients andphysicians education. J la State Med Soc. 2013; 165: 26-29.
33. Clemens MW, Medeiros LJ, Butler CE, et al. Complete surgical excision is essential for patients with breast implant-associated anaplastic large cell lymphoma. J Clin Oncol. 2015: 160-168.
34. Nava MB, Adams WP Jr, Botti G, MBN 2016 Aesthetic Breast Meeting BIA-ALCL Consensus Conference Report. Plast Reconstr Surg. 2018 Jan; 141(1): 40-48.
35. Beatriz EA, Miranda RN, Rauch GM, et al. Breast implantassociated anaplastic large cell lymphoma: sensitivity, specificity and findings of imaging studies in 44 patients. Breast Cancer Res Treat. 2014; 147(1): 1-14.
36. Bengtson BP, Van Natta BW, Murphy DK, et al. Style 410 highly cohesive silicone breast implant core study results at 3 years. Plast Reconstr Surg. 2007; 120: 40S-48S.
37. Hammond DC, Migliori MM, Caplin DA, et al. Mentor Contour Profile Gel implants: clinical outcomes at 6 years. Plast Reconstr Surg. 2012; 129: 1381-1391.
38. Maxwell GP, Van Natta BW, Murphy DK, et al. Natrelle style 410 form-stable silicone breast implants: core study results at 6 years. Aesthet Surg J. 2012; 32: 709-717.
39. Spears S, Murphy D, Slicton A. Inamed silicone breast implant core study results at 6 years. Plast Reconstr Surg. 2007; 120: 8S-16S.
40. Cunningham B. The Mentor Core Study on silicone MemoryGel breast implants. Plast Reconstr Surg. 2007; 120: 19S-29S.
41. Wong C, Samuel M, Tan B, et al. Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast Reconstr Surg. 2006; 118: 1224-1236.
42. Pollock H. Breast capsular contracture: a retrospective study of textured versus smooth silicone implants. Plast Reconstr Surg. 1993; 91: 123-130.
43. Henriksen T, Holmich L, Fryzek J, et al. Incidence and severity of short term complications after breast augmentation: results from a nationwide breast implant registry. Ann Plast Surg. 2005; 54: 343-350.
